We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Cardiology

Multidomain Rehabilitation Reduces Cardiovascular Events in Older Adults Post-Myocardial Infarction: Insights from the PIpELINe Trial

MedXY Editorial Team•Oct 7, 2025•Cardiology
cardiovascular outcomesmyocardial infarctionolder adults

Highlight

  • Multidomain rehabilitation reduced cardiovascular death or unplanned cardiovascular hospitalization risk by 43% within one year compared to usual care in older adults post-MI.
  • The intervention combined cardiovascular risk factor control, dietary counseling, and structured exercise training, tailored for patients aged 65 and older with impaired physical function.
  • Median participant age was 80 years, highlighting feasibility and benefit even in very elderly populations with multimorbidity.
  • No serious adverse events were associated with the intervention, supporting its safety.

Study Background and Disease Burden

Myocardial infarction (MI) remains a leading cause of morbidity and mortality worldwide, with a particularly high burden in older populations. Patients aged 65 years and older often present with impaired physical performance post-MI, along with multiple comorbidities that complicate recovery and increase risk of recurrent cardiovascular events. Traditional cardiac rehabilitation programs have proven benefits in younger populations but their efficacy and safety in the elderly, especially those with functional impairment, remain less clear. This represents an important unmet clinical need, as older adults constitute a growing demographic with distinct physiological and psychosocial challenges.

Multidomain rehabilitation strategies—combining cardiovascular risk factor management, nutrition, and tailored exercise—hold theoretical promise to improve outcomes by addressing the multifactorial contributors to cardiovascular risk and physical decline. Yet robust randomized evidence in older adults with reduced functional status after MI is sparse.

Study Design

This multicenter, randomized controlled trial was conducted in Italy and involved 512 patients aged ≥65 years (median age 80), all of whom had impaired physical performance assessed 1 month post-MI. Patients were randomized in a 2:1 ratio to either a multidomain rehabilitation intervention or usual care.

The intervention comprised:
– Comprehensive control of cardiovascular risk factors (e.g., hypertension, dyslipidemia, diabetes)
– Dietary counseling emphasizing heart-healthy nutrition
– Structured exercise training adapted to patient capacity

Usual care followed standard post-MI management without this integrated rehabilitation program. The primary composite outcome was cardiovascular death or unplanned hospitalization for cardiovascular causes within 1 year.

Key Findings

Among the 512 randomized patients (342 intervention, 170 control), the intervention group experienced a significantly lower incidence of the primary outcome (12.6% vs. 20.6%; hazard ratio [HR], 0.57; 95% CI, 0.36 to 0.89; P=0.01). This represents a 43% relative risk reduction in cardiovascular death or unplanned cardiovascular hospitalization over 12 months.

Cardiovascular death alone occurred less frequently in the intervention group (4.1% vs. 5.9%), though this did not reach statistical significance (HR, 0.69; 95% CI, 0.31 to 1.55). Unplanned cardiovascular hospitalizations were significantly lower in the intervention group (9.1% vs. 17.6%; HR, 0.48; 95% CI, 0.29 to 0.79).

Importantly, no serious adverse events related to the rehabilitation intervention were reported, highlighting its safety even in a vulnerable elderly cohort. Subgroup analyses suggested consistent benefit across sexes and age strata.

The robust effect sizes and the consistency of risk reduction primarily in hospitalization suggest that the multidomain program may improve both survival and quality of life by reducing recurrent or decompensated cardiovascular events.

Expert Commentary

This landmark randomized trial addresses a critical gap in evidence for cardiac rehabilitation in older MI survivors who often face a clinical conundrum balancing intervention intensity and safety. The trial’s pragmatic design and comprehensive intervention provide strong support for integrating multidomain rehabilitation in routine post-MI care pathways for the elderly.

The biological plausibility stems from the combined targeting of modifiable risk factors, nutritional optimization, and physical conditioning—all pivotal in vascular health, cardiac function, and preventing frailty progression. Previous observational studies underscored the association between functional impairment and poor cardiovascular outcomes; this trial establishes a causative improvement pathway.

Limitations include the single-country setting and potential variability in usual care standards internationally, though the elderly median age and inclusion criteria enhance generalizability to typical clinical populations encountered globally.

Current guidelines may soon incorporate such multidomain programs as a recommended standard for older MI patients with impaired physical function, shifting the paradigm from unidimensional post-MI rehabilitation to holistic interventions.

Conclusion

The PIpELINe trial provides compelling evidence that a multidomain rehabilitation approach—combining cardiovascular risk factor control, dietary counseling, and exercise therapy—is both safe and effective in reducing cardiovascular death or unplanned cardiovascular hospitalizations among older adults with functional impairment following myocardial infarction. This intervention not only addresses the heightened risk profile in this population but also underscores the importance of comprehensive, tailored rehabilitation programs in improving post-MI outcomes. Incorporating such strategies into clinical practice could lead to substantive reductions in morbidity, healthcare utilization, and improve quality of life in this vulnerable subset of patients.

Future research should explore long-term sustainability of benefits, cost-effectiveness, and integration of psychosocial and cognitive support domains to further optimize recovery trajectories.

References

1. Tonet E, Raisi A, Zagnoni S, et al. Multidomain Rehabilitation for Older Patients with Myocardial Infarction. N Engl J Med. 2025;393(10):973-982. doi:10.1056/NEJMoa2502799.

2. Anderson L, Oldridge N, Thompson DR, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2016;1(1):CD001800.

3. Forman DE, Brawner CA. Cardiac Rehabilitation for Older Adults: Challenges and Opportunities. J Am Coll Cardiol. 2020;75(15):1757-1767.

4. Franco OH, de Laet C, Peeters A, et al. Effects of physical activity on life expectancy with cardiovascular disease. Arch Intern Med. 2005;165(20):2355-2360.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Cardiovascular Risks of CAR-T Therapy in Older Adults: Insights from US Medicare DataAmong older adults receiving CAR-T therapy, 5.8% experienced major adverse cardiovascular events (MACE), associated with increased mortality. Pre-existing cardiac conditions heightened risk, underscoring the need for cardiovascular monitoriSep 19, 2026Intracoronary Imaging-Guided PCI: Updated Meta-Analysis Validates Cardiovascular Outcome BenefitsThis updated meta-analysis of 28 RCTs reveals significant reductions in cardiovascular events and mortality with intracoronary imaging-guided PCI versus angiography-guided PCI, highlighting the importance of lesion and geographic factors inSep 19, 2026Targeting the CCND1-PDK4 Axis to Promote Reparative Macrophage Phenotype and Mitigate Post-Myocardial Infarction Cardiac RemodelingThis article discusses the role of cyclin D1 (CCND1) in promoting reparative macrophage transition post-myocardial infarction, highlighting its therapeutic potential in reducing adverse cardiac remodeling through metabolic reprogramming.Sep 19, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Evaluating Targeted Vitamin D Supplementation Post-Myocardial Infarction: Insights from the TARGET-D Trial
The TARGET-D trial investigated whether vitamin D supplementation, titrated to achieve serum levels >40-80 ng/mL, reduces major adverse cardiovascular events after myocardial infarction but found no significant benefit in the primary com
Sep 17, 2026
Comparing 0/1-Hour vs 0/3-Hour High-Sensitivity Troponin Pathways for Suspected Acute Coronary Syndrome in Real-World PracticeThis randomized trial evaluates the safety and efficiency of the ESC 0/1-hour versus 0/3-hour high-sensitivity troponin pathways in suspected acute coronary syndrome, showing noninferior safety but no significant improvement in rapid dischaSep 17, 2026
Impact of Digitalis Glycosides on Cardiovascular Outcomes in HFmrEF and HFrEF: A Comprehensive Evidence SynthesisDigitalis glycosides reduce cardiovascular death or worsening heart failure events in HFmrEF and HFrEF patients over a median of 36–37 months, supported by randomized trials and meta-analyses highlighting their role in select heart failureSep 17, 2026